SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001396814-23-000077
Filing Date
2023-11-02
Accepted
2023-11-02 08:01:26
Documents
14
Period of Report
2023-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pcrx-20231102.htm   iXBRL 8-K 25213
2 EX-99.1 pcrx-9302023x991.htm EX-99.1 343594
6 PACIRA BIOSCIENCES LOGO pacirabiosciencesa01.jpg GRAPHIC 27796
  Complete submission text file 0001396814-23-000077.txt   562787

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20231102.xsd EX-101.SCH 1911
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20231102_lab.xml EX-101.LAB 24134
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20231102_pre.xml EX-101.PRE 12518
8 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20231102_htm.xml XML 2733
Mailing Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609
Business Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609 813-553-6680
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 231370161
SIC: 2834 Pharmaceutical Preparations